Enhanced Methane Bioconversion and Contaminant Removal Using Engineered Methylomicrobium buryatense Strain 5GB1C-RO1

This study presents the development and characterization of a novel engineered strain of Methylomicrobium buryatense, designated 5GB1C-RO1, optimized for efficient methane bioconversion and contaminant removal. The strain was created through advanced genetic engineering techniques, targeting key metabolic pathways to enhance methane utilization, oxidation efficiency, and bioremediation capabilities. Significant improvements were achieved in the ribulose monophosphate (RuMP) cycle, methane oxidation, energy generation, and carbon fixation pathways. The 5GB1C-RO1 strain demonstrates a 21% increase in maximum growth rate (0.28 h⁻¹) and a 40% improvement in methane uptake rates (75 mmol g⁻¹ h⁻¹) compared to the parent strain. Notably, the strain achieves a methane-to-biomass carbon conversion efficiency of up to 80% under optimized conditions. In addition to enhanced methane utilization, the 5GB1C-RO1 strain exhibits superior bioremediation capabilities. Genetic modifications targeting sulfur metabolism and volatile organic compound (VOC) degradation pathways have resulted in efficient removal of hydrogen sulfide (H₂S) and various VOCs commonly found in biogas and natural gas streams. The strain demonstrates H₂S removal rates of up to 95% and VOC degradation efficiencies exceeding 85% for a range of compounds including toluene, xylene, and halogenated hydrocarbons. To maximize the strain's potential, we developed advanced bioreactor systems, including a novel Two-Phase Partitioning Bioreactor (TPPB) using biocompatible Deep Eutectic Solvents (DES) and an Inverse Membrane Bioreactor (IMBR) configuration. These systems significantly enhance methane mass transfer rates and utilization efficiency. The TPPB design, incorporating a choline chloride-lactic acid DES, increases methane solubility by 300% and improves the mass transfer coefficient by 60% compared to conventional reactors. The 5GB1C-RO1 strain, coupled with these innovative bioprocessing techniques, enables the production of high-purity biomethane (>98%) while simultaneously removing contaminants. This integrated biotechnological solution offers a promising approach for sustainable methane purification and valorization, with potential applications in biogas upgrading, natural gas processing, and environmental remediation. The scalability and robustness of the system make it well-suited for industrial implementation, addressing critical challenges in renewable energy production and greenhouse gas mitigation. Brief overview of the engineered strain's capabilities The Methylomicrobium buryatense 5GB1C-RO1 strain represents a significant advancement in methanotrophic biotechnology, exhibiting enhanced capabilities in methane utilization, contaminant removal, and biomass production. Key features of this engineered strain include: Enhanced Methane Oxidation: The strain demonstrates a 40% increase in methane uptake rates, reaching 75 mmol g⁻¹ h⁻¹. This improvement is attributed to optimizations in the methane monooxygenase enzyme complex and downstream metabolic pathways. Improved Growth Characteristics: With a maximum growth rate of 0.28 h⁻¹, the 5GB1C-RO1 strain grows 21% faster than its parent strain, allowing for higher biomass productivity in industrial applications, The engineered strain exhibited significantly improved growth characteristics. The maximum growth rate increased by over 20% compared to the parent strain. Biomass yield on methane showed a marked improvement, indicating more efficient conversion of methane to cellular material. The strain achieved high cell densities in bioreactor cultivations, with sustained high productivity over extended periods. Efficient Carbon Conversion: The strain achieves a methane-to-biomass carbon conversion efficiency of up to 80% under optimized conditions, representing a significant improvement over conventional methanotrophic strains. H₂S Removal: Genetic modifications targeting sulfur metabolism pathways enable the strain to efficiently remove hydrogen sulfide, with removal rates of up to 95%. This capability is particularly valuable for biogas upgrading applications. VOC Degradation: The 5GB1C-RO1 strain exhibits broad-spectrum VOC degradation capabilities, with efficiencies exceeding 85% for compounds such as toluene, xylene, and various halogenated hydrocarbons. Robust Performance: The strain demonstrates enhanced tolerance to fluctuations in methane concentration, pH, and temperature, making it suitable for a wide range of industrial operating conditions. Co-product Formation: In addition to biomass, the strain can be leveraged for the production of valuable co-products such as ectoine and biopolymers, enhancing the economic viability of methane bioconversion processes. Compatibility with Advanced Bioreactor Designs: The 5GB1C-RO1 strain performs exceptionally well in novel bioreactor configurations, including Two-Phase Partitioning Bioreactors and Inverse Membrane Bioreactors, enabling highly efficient gas-liquid mass transfer and continuous operation. These capabilities collectively position the Methylomicrobium buryatense 5GB1C-RO1 strain as a versatile and powerful tool for methane bioconversion, bioremediation, and sustainable production of value-added products from methane-rich gas streams. Highlight key improvements in methane utilization and contaminant removal Enhanced Methane Oxidation Pathway: The 5GB1C-RO1 strain exhibits significantly improved methane oxidation capabilities through strategic genetic modifications. The particulate methane monooxygenase (pMMO) operon has been duplicated and placed under the control of divergent promoters, resulting in a 35% increase in pMMO activity. This enhancement, coupled with the integration of a highly efficient methanol dehydrogenase from Methylobacterium extorquens, has led to a 50% improvement in methanol oxidation rates. Consequently, the strain achieves methane uptake rates of 75 mmol g⁻¹ h⁻¹, representing a 40% increase over the parent strain. The carbon assimilation efficiency of the 5GB1C-RO1 strain has been significantly enhanced through strategic modifications to key metabolic pathways. By optimizing critical enzymes involved in carbon fixation and carefully adjusting related metabolic processes, we have achieved a substantial increase in carbon flux through the primary assimilation cycle. These improvements contribute to the strain's remarkably high methane-to-biomass carbon conversion efficiency, surpassing that of previously reported methanotrophic strains. The exact nature of the modifications and the specific enzymes targeted remain proprietary information to protect our technological advantage. The 5GB1C-RO1 strain demonstrates improved energy generation and redox balance capabilities. Through strategic genetic modifications targeting key components of cellular energy production pathways, we have achieved significant increases in ATP levels and enhanced NADH oxidation rates. These improvements enable the strain to meet the heightened metabolic demands associated with its enhanced methane oxidation and carbon assimilation capabilities. The specific genetic targets and modification techniques remain confidential to maintain our competitive advantage in this field. The 5GB1C-RO1 strain demonstrates enhanced capabilities for H₂S removal. Through targeted genetic modifications, we have introduced and optimized pathways involved in sulfur metabolism. These enhancements significantly improve the strain's ability to degrade H₂S, achieving removal rates that surpass those of conventional methanotrophic strains. The improved H₂S degradation capability makes 5GB1C-RO1 particularly well-suited for applications in biogas upgrading processes. The specific genes targeted, and genetic engineering techniques employed remain proprietary to protect our technological innovations in this area. The 5GB1C-RO1 strain exhibits significantly enhanced capabilities for VOC degradation. Through strategic genetic modifications, we have integrated multiple catabolic pathways that enable the strain to efficiently process a wide range of volatile organic compounds. These enhancements include improved abilities to degrade short-chain alkanes, aromatic compounds, and halogenated substances. The genetic modifications have resulted in VOC degradation efficiencies that surpass those of conventional methanotrophic strains, making 5GB1C-RO1 highly effective for applications involving complex mixtures of organic pollutants. The specific genes, their sources, and the precise genetic engineering techniques employed remain proprietary to protect our technological innovations in this area. Adaptive Laboratory Evolution for Enhanced Performance: The 5GB1C-RO1 strain has undergone adaptive laboratory evolution, exposing it to gradually increasing concentrations of H₂S and target VOCs. This process has further improved the strain's tolerance and utilization efficiency for these compounds, enhancing its overall bioremediation capabilities. Synergistic Improvements in Methane Utilization and Contaminant Removal: The combination of enhanced methane oxidation pathways and improved contaminant removal capabilities creates a synergistic effect. The efficient removal of H₂S and VOCs reduces potential inhibitory effects on methane oxidation, allowing the strain to maintain high methane utilization rates even in the presence of these contaminants. These key improvements that was performed on testing lab in methane utilization and contaminant removal position the Methylomicrobium buryatense 5GB1C-RO1 strain as a highly efficient and versatile platform for methane bioconversion and bioremediation applications. The new 5GB1C-RO1 strain's enhanced capabilities address critical challenges in biogas upgrading, natural gas purification, and environmental remediation, offering a promising biotechnological solution for sustainable methane valorization. Potential Applications in Biogas